Literature mining on pharmacokinetics numerical data: A feasibility study

Journal of Biomedical Informatics

Volumn 42, Issue 4, 2009, Pages 726-735

  Wang, Zhiping ^a   Kim, Seongho ^a   Quinney, Sara K ^a   Guo, Yingying ^b   Hall, Stephen D ^b   Rocha, Luis M ^c,d   Li, Lang ^a  

^a Indiana University   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c INDIANA UNIVERSITY   (United States)

^d INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

Clearance; Data mining; Entity recognition; Information extraction; Linear mixed model; Midazolam; Pharmacokinetics

Indexed keywords

CLEARANCE; ENTITY RECOGNITION; INFORMATION EXTRACTION; LINEAR MIXED MODEL; MIDAZOLAM;

ANESTHETICS; DECISION MAKING; INFORMATION ANALYSIS; INFORMATION MANAGEMENT; PHARMACOKINETICS; PLANNING; PROBABILITY DISTRIBUTIONS; RESOURCE ALLOCATION;

MINING;

ALPRAZOLAM; AMLODIPINE; DIAZEPAM; MIDAZOLAM; NIFEDIPINE; NITRENDIPINE; RIFAMPICIN; TRIAZOLAM;

ARTICLE; CONTROLLED STUDY; DATA EXTRACTION; DATA MINING; DRUG CLEARANCE; FEASIBILITY STUDY; HUMAN; INFORMATION PROCESSING; MEDICAL RESEARCH; PRIORITY JOURNAL;

ALGORITHMS; ARTIFICIAL INTELLIGENCE; DATABASES, FACTUAL; HUMANS; INFORMATION STORAGE AND RETRIEVAL; LINEAR MODELS; MIDAZOLAM; MODELS, BIOLOGICAL; PHARMACOKINETICS; PUBMED; REPRODUCIBILITY OF RESULTS;

EID: 67649382957     PISSN: 15320464     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbi.2009.03.010     Document Type: Article

References (28)

1. Woosley R.L., and Cossman J. Drug development and the FDA's critical path initiative. Clin Pharmacol Ther 81 (2007) 129-133
2. Veit M. New strategies for drug development. Berl Munch Tierarztl Wochenschr 117 (2004) 276-287
3. D'Andrea G., D'Ambrosio R.L., Di Perna P., Chetta M., Santacroce R., Brancaccio V., et al. A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. Blood 105 (2005) 645-649
4. Kirchheiner J., and Brockmoller J. Clinical consequences of cytochrome P450 2C9 polymorphisms. Clin Pharmacol Ther 77 (2005) 1-16
5. Badagnani I., Castro R.A., Taylor T.R., Brett C.M., Huang C.C., Stryke D., et al. Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants. J Pharmacol Exp Ther 318 (2006) 521-529
6. Hung S.I., Chung W.H., Jee S.H., Chen W.C., Chang Y.T., Lee W.R., et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genom 16 (2006) 297-306
7. Food and Drug Administration. Innovation or stagnation: challenges and opportunity on the critical path to new medical products; 2004. Available from: http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.html.
8. Food and Drug Administration. Critical path opportunity list; 16 March 2004. Available from: http://www.fda.gov/oc/initiatives/criticalpath/reports/opp_list.pdf.
9. Food and Drug Administration. Critical path opportunity report; 2006. Available from: http://www.fda.gov/oc/initiatives/criticalpath/projectsummary/consortium.html.
10. Lalonde R.L., Kowalski K.G., Hutmacher M.M., Ewy W., Nichols D.J., Milligan P.A., et al. Model-based drug development. Clin Pharmacol Ther 82 1 (2007) 21-32
11. Chang M., Kenley S., Bull J., Chiu Y.Y., Wang W., Wakeford C., et al. Innovative approaches in drug development. J Biopharm Stat 17 5 (2007) 775-789
12. O'Neill R.T. FDA's critical path initiative: a perspective on contributions of biostatistics. Biom J 48 4 (2006) 559-564
13. Chien J.Y., Friedrich S., Heathman M.A., de Alwis D.P., and Sinha V. Pharmacokinetics/pharmacodynamics and the stages of drug development: role of modeling and simulation. AAPS J 7 3 (2005) E544-E559
14. Pustejovsky J, Castaño J, Zhang J, Kotecki M, Cochran B. Robust relational parsing over biomedical literature: extracting inhibit relations. In: Proceedings of the seventh pacific symposium on biocomputing world scientific, Hawaii; 2002. p. 362-73.
15. Thompson D.F., and Williams N.C. Tracking the growth of drug therapy literature using PubMed. Drug Inform J 41 4 (2007) 449-455
16. Shatkay H., and Feldman R. Mining the biomedical literature in the genomic era: an overview. J Comput Biol 10 6 (2003) 821-855
17. Jensen L.J., Saric J., and Brok P. Literature mining for the biologist: from information retrieval to biological discovery. Nat Rev Genet 7 (2006) 119-129
18. Joachims T. Making large-scale SVM learning practical. In: Schölkopf B., Burges C., and Smola A. (Eds). Advances in kernel methods - support vector learning (1999), MIT-Press
19. Yeh A.S., Hirschman L., and Morgan A.A. Evaluation of text data mining for database curation: lessons learned from the KDD challenge cup. ISMB (Suppl Bioinform) (2003) 331-339
20. Hersh W, Cohen AM, Roberts P, Rekapalli HK. TREC 2006 genomics track overview. In: TREC 2006 notebook; 2006. p. 68.
21. Hirschman L., Yeh A., Blaschke C., and Valencia A. Overview of BioCreAtIvE: critical assessment of information extraction for biology. BMC Bioinform 6 Suppl. 1 (2005) S1
22. Pentikäinen P.J., Valisalmi L., Himberg J.J., and Crevoisier C. Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjects. J Clin Pharmacol 29 3 (1989) 272-277
23. opennlp. Available from: http://opennlp.sourceforge.net/index.html.
24. Reynar JC, Ratnaparkhi A. A maximum entropy approach to identifying sentence boundaries. In: Proceedings of the fifth conference on applied natural language processing; 1997.
25. Porter M.F. An algorithm for suffix stripping. Program 14 3 (1980) 130-137
26. Metabolism and transport drug interaction database. Available from: http://depts.washington.edu/didbase; 1999-2003 [accessed: 03.07]. Copyright University of Washington.
27. Wall M.E., Rechtsteiner A., and Rocha L.M. Singular value decomposition and principal component analysis. In: Berrar D.P., Dubitzky W., and Granzow M. (Eds). A practical approach to microarray data analysis (2003), Kluwer, Norwell, MA 91-109
28. Yu M., Kim S., Wang Z., Hall S., and Li L. A Bayesian meta-analysis on published sample mean and variance pharmacokinetic data with application to drug-drug interaction prediction. J Biopharm Stat 18 6 (2008) 1063-1083